Viewpoints » The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

04/05/2024Viewpoint

The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

In light of the rising rates of sexually transmitted infections (STIs), urgent care clinics have found themselves at a crucial crossroads. PCR (Polymerase Chain Reaction) testing at the point of care emerges as a potential game-changer.

The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

In light of the rising rates of sexually transmitted infections (STIs), urgent care clinics have found themselves at a crucial crossroads. The challenge? Finding a testing solution that not only meets the clinical needs of patients but also aligns with the operational workflow and the financial goals of the clinic; PCR (Polymerase Chain Reaction) testing at the point of care emerges as a potential game-changer.

Addressing Concerns about PCR at the Point of Care

Many urgent care leaders express concerns about incorporating PCR (Polymerase Chain Reaction) testing at the point of care, mainly due to potential workflow disruption and concerns about cost and profitability.

We hear you. The thought of lengthening patient visits due to PCR and patient counseling may seem daunting. However, it’s essential to consider the long-term benefits that PCR at the point of care can offer, both operationally and financially.

The Value of PCR at the Point of Care

PCR at the point of care offers numerous advantages that can significantly enhance your urgent care clinic’s efficiency, profitability, and patient experience.

PCR at the point of care can seamlessly fit into your existing workflow and streamline your operations. Instead of managing the logistics and costs associated with send-out testing, clinics can perform testing on-site, delivering results and appropriate treatment during the visit and reducing the time spent on patient callbacks.

PCR at the point of care can unlock potential economic value for your clinic. While the cost of the Visby Medical Sexual Health Test may be a concern, it’s crucial to consider the broader financial picture. By improving the patient encounter, clinics can potentially explore other billing opportunities, offsetting the test’s cost and potentially even increasing overall profitability.

Additionally, incorporating PCR at the point of care provides clinics with the opportunity to offer cash pay options for patients seeking additional privacy, which can further enhance service appeal and satisfaction.

Most importantly, using PCR at the point of care for STI can significantly enhance the patient experience as it dramatically reduces patient anxiety by eliminating the stress of waiting for test outcomes and follow-up appointments. Rapid, reliable testing results lead to quicker treatment and improved patient satisfaction, differentiating your clinic in a competitive market.

Unlock the Potential of PCR at the Point of Care

In the face of rising STI rates, urgent care clinics must adapt and evolve. By incorporating PCR at the point of care, clinics can address the increasing demand for STI testing while improving operational efficiency, profitability, and patient experience.

So, as you consider the next steps for your clinic, remember: PCR at the point of care isn’t just about changing a testing method. It’s about empowering your clinic to provide better care, drive revenue growth, and stand out amongst competitors in the urgent care landscape.

The choice is clear. It’s time to embrace PCR at the point of care. It’s time to transform STI testing in urgent care clinics.

Are you ready to redefine STI testing in your urgent care clinic with PCR at the point of care? Contact us today to learn more about how you can seamlessly integrate this revolutionary testing method into your practice. Together, we can enhance patient satisfaction, streamline operations, and uncover new paths to profitability.

Take the first step towards a future where high-quality care meets operational excellence. Reach out now—because your clinic and your patients deserve the best.

→ Get in touch to learn more

Read more articles & insights

03/14/2024Viewpoint

Understanding the Financial Impact of PCR Point of Care Testing for STIs

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

Read More
Understanding the Financial Impact of PCR Point of Care Testing for STIs

03/07/2024Viewpoint

5 Frequently Asked Questions on Implementing PCR into Urgent Care

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

Read More
5 Frequently Asked Questions on Implementing PCR into Urgent Care

02/21/2024Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares